Cargando…
Development and evaluation of an inactivated coxsackievirus A16 vaccine in gerbils
Coxsackievirus A16 (CVA16) is one of the major pathogens responsible for human hand, foot, and mouth disease (HFMD), which has threatened the health of young children, particularly in Asia-Pacific nations. Vaccination is an effective strategy for protecting children from CVA16 infection. However, th...
Autores principales: | Sun, Yi-Sheng, Xia, Yong, Xu, Fang, Lu, Hang-Jing, Mao, Zi-An, Gao, Meng, Pan, Tian-Yuan, Yao, Ping-Ping, Wang, Zhen, Zhu, Han-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377242/ https://www.ncbi.nlm.nih.gov/pubmed/35787233 http://dx.doi.org/10.1080/22221751.2022.2093132 |
Ejemplares similares
-
Coxsackievirus A16 induced neurological disorders in young gerbils which could serve as a new animal model for vaccine evaluation
por: Sun, Yi-Sheng, et al.
Publicado: (2016) -
A Bivalent Inactivated Vaccine Prevents Enterovirus 71 and Coxsackievirus A16 Infections in the Mongolian Gerbil
por: Yi, Eun-Je, et al.
Publicado: (2023) -
Global Gene Expression Analysis of the Brainstem in EV71- and CVA16-Infected Gerbils
por: Sun, Yi-Sheng, et al.
Publicado: (2019) -
Optimization and Characterization of Candidate Strain for Coxsackievirus A16 Inactivated Vaccine
por: Li, Jingliang, et al.
Publicado: (2015) -
Efficacy of a coxsackievirus A6 vaccine candidate in an actively immunized mouse model
por: Qian, Sha-Sha, et al.
Publicado: (2021)